CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Rebuilding Trust in Society ssir.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ssir.org Daily Mail and Mail on Sunday newspapers.
Digital Transformation Of Financial Services Expected To Continue In 2023, As Fintech Ecosystem Matures crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.
All estimates of protection waned within months against reinfection but remained high
and sustained for hospital admission or severe disease. Individuals with hybrid immunity
had the highest magnitude and durability of protection, and as a result might be able
to extend the period before booster vaccinations are needed compared to individuals
who have never been infected.